rs35848863

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_022455.5(NSD1):​c.6750G>A​(p.Met2250Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0516 in 1,614,000 control chromosomes in the GnomAD database, including 2,507 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar.

Frequency

Genomes: 𝑓 0.049 ( 199 hom., cov: 30)
Exomes 𝑓: 0.052 ( 2308 hom. )

Consequence

NSD1
NM_022455.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.0770

Publications

24 publications found
Variant links:
Genes affected
NSD1 (HGNC:14234): (nuclear receptor binding SET domain protein 1) This gene encodes a protein containing a SET domain, 2 LXXLL motifs, 3 nuclear translocation signals (NLSs), 4 plant homeodomain (PHD) finger regions, and a proline-rich region. The encoded protein enhances androgen receptor (AR) transactivation, and this enhancement can be increased further in the presence of other androgen receptor associated coregulators. This protein may act as a nucleus-localized, basic transcriptional factor and also as a bifunctional transcriptional regulator. Mutations of this gene have been associated with Sotos syndrome and Weaver syndrome. One version of childhood acute myeloid leukemia is the result of a cryptic translocation with the breakpoints occurring within nuclear receptor-binding Su-var, enhancer of zeste, and trithorax domain protein 1 on chromosome 5 and nucleoporin, 98-kd on chromosome 11. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Sep 2018]
NSD1 Gene-Disease associations (from GenCC):
  • Beckwith-Wiedemann syndrome due to NSD1 mutation
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Sotos syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
  • Sotos syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0012430251).
BP6
Variant 5-177294118-G-A is Benign according to our data. Variant chr5-177294118-G-A is described in ClinVar as Benign. ClinVar VariationId is 96070.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.075 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NSD1NM_022455.5 linkc.6750G>A p.Met2250Ile missense_variant Exon 23 of 23 ENST00000439151.7 NP_071900.2 Q96L73-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NSD1ENST00000439151.7 linkc.6750G>A p.Met2250Ile missense_variant Exon 23 of 23 1 NM_022455.5 ENSP00000395929.2 Q96L73-1

Frequencies

GnomAD3 genomes
AF:
0.0487
AC:
7401
AN:
152058
Hom.:
198
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0549
Gnomad AMI
AF:
0.0406
Gnomad AMR
AF:
0.0326
Gnomad ASJ
AF:
0.0153
Gnomad EAS
AF:
0.0177
Gnomad SAS
AF:
0.0818
Gnomad FIN
AF:
0.0418
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0515
Gnomad OTH
AF:
0.0436
GnomAD2 exomes
AF:
0.0467
AC:
11724
AN:
251202
AF XY:
0.0485
show subpopulations
Gnomad AFR exome
AF:
0.0592
Gnomad AMR exome
AF:
0.0198
Gnomad ASJ exome
AF:
0.0185
Gnomad EAS exome
AF:
0.0191
Gnomad FIN exome
AF:
0.0434
Gnomad NFE exome
AF:
0.0501
Gnomad OTH exome
AF:
0.0466
GnomAD4 exome
AF:
0.0519
AC:
75817
AN:
1461824
Hom.:
2308
Cov.:
34
AF XY:
0.0528
AC XY:
38398
AN XY:
727208
show subpopulations
African (AFR)
AF:
0.0570
AC:
1910
AN:
33480
American (AMR)
AF:
0.0218
AC:
974
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0194
AC:
507
AN:
26136
East Asian (EAS)
AF:
0.0173
AC:
688
AN:
39700
South Asian (SAS)
AF:
0.0837
AC:
7217
AN:
86258
European-Finnish (FIN)
AF:
0.0446
AC:
2378
AN:
53378
Middle Eastern (MID)
AF:
0.0671
AC:
387
AN:
5768
European-Non Finnish (NFE)
AF:
0.0527
AC:
58639
AN:
1111986
Other (OTH)
AF:
0.0516
AC:
3117
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
4986
9972
14958
19944
24930
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2208
4416
6624
8832
11040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0487
AC:
7410
AN:
152176
Hom.:
199
Cov.:
30
AF XY:
0.0478
AC XY:
3556
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.0549
AC:
2278
AN:
41500
American (AMR)
AF:
0.0326
AC:
498
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0153
AC:
53
AN:
3472
East Asian (EAS)
AF:
0.0178
AC:
92
AN:
5176
South Asian (SAS)
AF:
0.0816
AC:
393
AN:
4814
European-Finnish (FIN)
AF:
0.0418
AC:
443
AN:
10598
Middle Eastern (MID)
AF:
0.0544
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
0.0515
AC:
3503
AN:
68004
Other (OTH)
AF:
0.0460
AC:
97
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
358
716
1074
1432
1790
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0495
Hom.:
746
Bravo
AF:
0.0469
TwinsUK
AF:
0.0580
AC:
215
ALSPAC
AF:
0.0498
AC:
192
ESP6500AA
AF:
0.0590
AC:
260
ESP6500EA
AF:
0.0488
AC:
420
ExAC
AF:
0.0492
AC:
5970
Asia WGS
AF:
0.0930
AC:
324
AN:
3478
EpiCase
AF:
0.0491
EpiControl
AF:
0.0449

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 10, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jun 13, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Sotos syndrome Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
11
DANN
Benign
0.95
DEOGEN2
Benign
0.067
.;T;.
Eigen
Benign
-0.78
Eigen_PC
Benign
-0.74
FATHMM_MKL
Benign
0.056
N
LIST_S2
Benign
0.71
T;T;.
MetaRNN
Benign
0.0012
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.69
.;N;.
PhyloP100
0.077
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-0.73
N;N;N
REVEL
Benign
0.066
Sift
Benign
0.043
D;D;D
Sift4G
Benign
0.17
T;T;T
Polyphen
0.095
B;B;B
Vest4
0.11
MutPred
0.057
.;Loss of catalytic residue at M2250 (P = 0.0214);.;
MPC
0.16
ClinPred
0.0019
T
GERP RS
1.5
Varity_R
0.070
gMVP
0.12
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35848863; hg19: chr5-176721119; COSMIC: COSV61770840; COSMIC: COSV61770840; API